Chemistry Services
Product Description
Sterling Pharma Solutions
-
GB
-
2016On CPHI since
-
4Certificates
-
1000 - 4999Employees
Company types
Primary activities
Sterling Pharma Solutions
-
GB
-
2016On CPHI since
-
4Certificates
-
1000 - 4999Employees
Company types
Primary activities
More Products from Sterling Pharma Solutions (4)
-
Product ADC development
More than 30 years' experience in ADC development and specialist bioconjugation services. -
Product ADC manufacturing
Sterling’s dedicated bioconjugation facility, located in Deeside, Wales, can handle a variety of batch sizes to support cGMP clinical and preclinical manufacture of antibody drug conjugates (ADCs) and bioconjugates. Through our integrated global network, we are also capable of manufacturing linker payloads... -
Product Small molecule API development
At Sterling we have extensive API Development capabilities ranging from route scouting and design, through to process optimisation and full validation support, including quality by design (QbD). As a PDMO®, science is at the core of everything that we do and underpins our approach to API Development, coupl... -
Product Small molecule API manufacturing
Scalable small molecule API manufacturing, from grams to tons: Our flexible and tailored approach to API manufacturing enables us to support even the most specialised and complex project requirements. Our facilities in the UK, EU and US are equipped with state-of-the-art API manufacturing equipment to supp...
Sterling Pharma Solutions resources (8)
-
News Sterling Pharma and MIB partner to develop low-cost route to new oral COVID drug
The new route uses a novel enzyme, cytidine aminotransferase, which would reduce the manufacturing cost of the drug -
News Sterling Pharma Solutions signs up to manufacture OncoTEX's ovarian cancer drug
The CDMO's expertise and capabilities a "perfect fit" for overcoming the challenges of manufacturing this complex molecule -
News Sterling Pharma seals acquisition of bioconjugation specialist ADC
By integrating its HPAPI capabilities with those at ADC Biotechnologies' Deeside facility, small molecule CDMO will be able to offer the development and manufacturing of toxin linkers -
News Sterling paves the way for ADC Bio acquisition with strategic partnership
UK-based CDMO makes ‘significant investment’ as companies combine HPAPI small molecule expertise with antibody drug conjugate specialism -
News Sterling Pharma Solutions acquires API facility in US
Sterling Pharma Solutions has acquired the Alcami facility in Germantown, Wisconsin, US. -
News Sterling Pharma Solutions launches £11 million Material Science Centre
Sterling has launched its multi-million-pound Material Science Centre at its headquarters in Dudley, Northumberland, UK. -
News Sterling Pharma Solutions launches £11 million Material Science Centre
The new centre will allow the company to improve efficiencies and reduce overall manufacturing time. -
News Meet our Solid State specialists
This month we launch our multi-million-pound Material Science Centre, home to our Solid State specialists, as well as our new milling, micronisation and solid state chemistry services. Here, the team introduce themselves and share a little more about their experiences with solid state chemistry.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance